Lee Boram, Ahn Eun Kyoung, Yang Changsop
KM Science Research Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
KM Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Evid Based Complement Alternat Med. 2022 Jan 29;2022:3306420. doi: 10.1155/2022/3306420. eCollection 2022.
BACKGROUND: Herbal medicine is widely used for the treatment of functional dyspepsia (FD) in East Asian countries. We aimed to analyze the prescription patterns of herbal medicine for patients with FD in Korean medicine clinical settings through the analysis of national health insurance claims data over the past 10 years and to check how herbal medicine has been used for FD within the scope of national health insurance. METHODS: All prescription data claimed to the Health Insurance Review and Assessment Service with the diagnosis of FD and herbal medicine prescriptions in 2010-2019 were reviewed. We estimated the demographics, clinical characteristics, and annual prescription amount and cost of each herbal medicine. Frequent comorbidities of FD were investigated by analyzing the frequency of the Korean standard classification of diseases codes used together with FD. RESULTS: In total, 19,388,248 herbal medicine prescriptions were identified. Herbal medicine prescriptions were mostly claimed by women, the elderly, outpatients at Korean medicine clinics, and national health insurance; the number increased every year. The most frequently prescribed herbal medicine was () (31.12%), followed by () (23.20%), () (6.31%), and () (6.25%). The total cost of herbal medicine prescriptions increased every year, and it was highest for () (19.37%), followed by () (17.50%) and then () (15.63%). Musculoskeletal and connective tissue diseases including low back pain and myalgia were the commonest comorbidities associated with FD. CONCLUSION: This is the first study to investigate the disease burden and actual prescription pattern of herbal medicine for FD using claim data. Future clinical research and related healthcare policies should be established based on our study.
背景:在东亚国家,草药被广泛用于治疗功能性消化不良(FD)。我们旨在通过分析过去10年的国家健康保险理赔数据,来分析韩医临床环境中FD患者的草药处方模式,并检查在国家健康保险范围内草药是如何用于FD治疗的。 方法:回顾了2010 - 2019年向健康保险审查和评估服务机构申报的所有诊断为FD的处方数据以及草药处方。我们估算了每种草药的人口统计学特征、临床特征、年度处方量和成本。通过分析与FD一起使用的韩国疾病标准分类代码的频率,调查了FD常见的合并症。 结果:共识别出19388248份草药处方。草药处方大多由女性、老年人、韩医诊所的门诊患者以及国家健康保险申报;数量逐年增加。最常开具的草药是(此处原文草药名称缺失)(31.12%),其次是(此处原文草药名称缺失)(23.20%)、(此处原文草药名称缺失)(6.31%)和(此处原文草药名称缺失)(6.25%)。草药处方的总成本逐年增加,其中(此处原文草药名称缺失)最高(19.37%),其次是(此处原文草药名称缺失)(17.50%),然后是(此处原文草药名称缺失)(15.63%)。包括腰痛和肌痛在内的肌肉骨骼和结缔组织疾病是与FD相关的最常见合并症。 结论:这是第一项利用理赔数据调查FD草药疾病负担和实际处方模式的研究。应基于我们的研究制定未来的临床研究和相关医疗政策。
Evid Based Complement Alternat Med. 2022-1-29
Medicine (Baltimore). 2022-9-2
BMC Complement Altern Med. 2014-3-7
Integr Med Res. 2020-9
Chin Herb Med. 2023-9-29
J Neurogastroenterol Motil. 2023-7-30
Front Med (Lausanne). 2021-7-26
Ann Geriatr Med Res. 2019-6
Therap Adv Gastroenterol. 2018-7-16
J Neurogastroenterol Motil. 2018-10-1
Health Qual Life Outcomes. 2018-5-2
United European Gastroenterol J. 2018-2